Commentary
Podcast
The updated version of the Oncology Care Model (OCM) incentivizes value-based care over volume, but some wonder if it is enough.
This month, we spoke with Bobby Green, MD, President and Chief Medical Officer at Thyme Care, Nashville, Tennessee. Green walks pharmacists through one of the most impactful payment models in oncology today, providing a natural break down of the enhancing oncology model (EOM) and how it works for patients and health care providers in Medicare and Medicaid.
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia